Invacare (IVC) → Stock, financial statements
Advertising

Invacare: stocks, financial statements

Dividends News
Favorites

Invacare Corp. engages in the manufacture and distribution of medical equipment used in non-acute care settings. It focuses on medical device solutions for congenital, acquired, and degenerative ailments. It operates through the following segments: Europe, NA/HME, Institutional Products Group, and Asia Pacific. The Europe segment involves in the sale of lifestyle, mobility and seating, and respiratory therapy products, as well as medical equipment, health care furnishings and accessory products. The NA/HME segment sells each of the three primary product lines including lifestyle, mobility and seating, and respiratory therapy products. The Institutional Products Group segment sells, and rented long-term care medical equipment, health care furnishings, and accessory products. The Asia Pacific segment is the sale of products similar to NA/HME and Institutional Products Group segments such as lifestyle, mobility and seating, and respiratory therapy products, as well as medical equipment, health care furnishings and accessory products. The company was founded by Aaron Malachi Mixon III in 1979 and is headquartered in Elyria, OH.

  • IVC Ticker
  • 🇺🇸 NYSE Exchange
  • 4,200 Employees
4 rated
comming soon
comming soon
comming soon
comming soon
comming soon
comming soon
comming soon
comming soon
comming soon

Financial statements — Invacare

The information is not 100% up-to-date. There may be errors or missing information. Some information is often missing, and, although there are almost no errors, I can't rule them out. Right now, I'm looking for a supplier of high-quality information, but so far what I'm finding is expensive (about $2000 a year). You can help my project here.
20 ← 16 2020 2019 2018 2017 2016
Total Revenue
850M 930M 970M 970M 1B
Cost Of Revenue
610M 670M 700M 700M 760M
Gross Profit
250M 260M 270M 270M 280M
Research and Development
0 0 0 0 0
Selling General and Admin
240M 260M 280M 300M 300M
Operating Expense
840M 930M 990M 990M 1.1B
Operating Income
8.9M 2M -14M -28M -20M
Other Income Expense Net
0 0 0 0 0
EBIT
8.9M 2M -14M -28M -20M
Interest Income
28M 29M 28M 22M 16M
Pretax Income
-24M -44M -34M -66M -30M
Income Tax
3.8M 9.3M 9.8M 10M 13M
Minority Interest
0 0 0 0 0
Net Income
-28M -53M -44M -77M -43M
Net Income Basic
-28M -53M -44M -77M -43M
20 ← 16 2020 2019 2018 2017 2016
Current cash
110M 80M 120M 180M 120M
Short term investments
17M 15M 14M 15M 17M
Receivables
140M 140M 140M 140M 130M
Inventory
120M 120M 130M 120M 140M
Other current assets
17M 15M 14M 15M 17M
Current assets
370M 360M 400M 460M 410M
Long term investments
570M 500M 490M 610M 490M
Property plant equipment
56M 47M 74M 80M 75M
Goodwill
400M 370M 380M 400M 360M
Intangible assets
28M 26M 27M 30M 29M
Other assets
65M 28M 4M 95M 27M
Total assets
950M 850M 890M 1.1B 900M
Accounts payable
85M 88M 92M 91M 88M
Current long term debt
9M 2.6M 2.1M 2M 15M
Other current liabilities
140M 130M 100M 130M 120M
Total current liabilities
230M 220M 200M 220M 220M
Long term debt
300M 250M 260M 350M 180M
Other liabilities
42M 38M 41M 42M 49M
Minority Interest
0 0 0 0 0
Total Liabilities
610M 540M 530M 640M 480M
Common stock
34M 34M 33M 33M 32M
Retained earning
59M 87M 140M 190M 270M
Treasury stock
-110M -100M -100M -100M -100M
Capital surplus
Shareholder equity
330M 310M 360M 420M 420M
Net tangible assets
-96M -91M -49M -8.2M 33M
20 ← 16 2020 2019 2018 2017 2016
Net Income
-28M -53M -44M -77M -43M
Depreciation
21M 24M 16M 15M 15M
Changes in receivables
-3.4M 1.5M -5M 11M -21M
Changes in inventories
-5M -7.6M 6.2M -14M 2.8M
Cash change
25M -37M -60M 52M 64M
Cash flow
22M 2.7M -46M -26M -57M
Capital expenditures
-22M -11M -9.8M -15M -10M
Investments
Investing activity other
Total investing cash flows
-9.5M -12M -6.4M -15M 3.6M
Dividends paid
Net borrowings
190M 150M 130M 160M 51M
Other financing cash flows
Cash flow financing
6.3M -28M -2.9M 88M 120M
Exchange rate effect